Matches in Wikidata for { <http://www.wikidata.org/entity/Q66038957> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q66038957 description "clinical trial" @default.
- Q66038957 description "ensayu clínicu" @default.
- Q66038957 description "klinisch onderzoek" @default.
- Q66038957 description "клінічне випробування" @default.
- Q66038957 description "կլինիկական փորձարկում" @default.
- Q66038957 name "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 name "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 type Item @default.
- Q66038957 label "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 label "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 prefLabel "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 prefLabel "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 P1050 Q66038957-CAD4BF0F-B08E-4081-A497-6F77D778969B @default.
- Q66038957 P1132 Q66038957-DD15B389-9A89-4A74-8219-FCFF2E2B9D13 @default.
- Q66038957 P1476 Q66038957-B9CB2A59-8DAC-464D-9BCF-762E35CBFD2E @default.
- Q66038957 P17 Q66038957-AD16E233-C709-4B4C-A64A-BA71ED5B8E62 @default.
- Q66038957 P17 Q66038957-B3BD9B07-20FB-412F-B339-D07006AA3835 @default.
- Q66038957 P17 Q66038957-B9CBF7B4-6999-4BB2-82C8-6D49699CB7A7 @default.
- Q66038957 P17 Q66038957-DD7B5C0C-38AA-4974-B385-CFD5C63B3738 @default.
- Q66038957 P17 Q66038957-E40EF874-F1FE-48DC-8D9D-D43847DCDD73 @default.
- Q66038957 P2899 Q66038957-3AEE3EEA-2839-4734-9A2C-DC0981638397 @default.
- Q66038957 P3098 Q66038957-909126F9-948A-4EAA-8559-9B11DA31A6B9 @default.
- Q66038957 P31 Q66038957-8B3C825B-E794-45D2-A9C4-F78209057846 @default.
- Q66038957 P580 Q66038957-F2A2BA25-EAE4-4E16-9EF8-D07C91C75D91 @default.
- Q66038957 P6099 Q66038957-8AAE7BBE-A4CC-4D36-BB3F-3C739DF672EC @default.
- Q66038957 P6099 Q66038957-EB49CABE-5E77-4DFE-A4FE-1840BFA1F35C @default.
- Q66038957 P8363 Q66038957-DC70EE85-7DB5-4700-B541-1DF6BA139624 @default.
- Q66038957 P1050 Q6065599 @default.
- Q66038957 P1132 "+466" @default.
- Q66038957 P1476 "A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis" @default.
- Q66038957 P17 Q28 @default.
- Q66038957 P17 Q30 @default.
- Q66038957 P17 Q31 @default.
- Q66038957 P17 Q36 @default.
- Q66038957 P17 Q55 @default.
- Q66038957 P2899 "+18" @default.
- Q66038957 P3098 "NCT00034476" @default.
- Q66038957 P31 Q30612 @default.
- Q66038957 P580 "2001-10-01T00:00:00Z" @default.
- Q66038957 P6099 Q42824440 @default.
- Q66038957 P6099 Q5452194 @default.
- Q66038957 P8363 Q78089383 @default.